lvv-hemorphin-7 has been researched along with Depression in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camargo-Silva, G; Costa, EA; da Cruz, KR; Galdino, P; Ghedini, PC; Gomes, KP; Ianzer, D; Mendonça, MM; Rodrigues-Silva, C; Santos, RAS; Turones, LC; Xavier, CH | 1 |
| Beyer, CE; Dwyer, JM; Lin, Q; Ling, HP; Luo, B; Mark, RJ; Neal, S; Platt, BJ; Rosenzweig-Lipson, S; Schechter, LE | 1 |
2 other study(ies) available for lvv-hemorphin-7 and Depression
| Article | Year |
|---|---|
The hemoglobin derived peptide LVV-hemorphin-7 evokes behavioral effects mediated by oxytocin receptors.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Behavior, Animal; Depression; Diazepam; Hemoglobins; Hormone Antagonists; Imipramine; Male; Motor Activity; Peptide Fragments; Rats; Rats, Wistar; Receptors, Oxytocin; Vasotocin | 2017 |
Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation.
Topics: Amygdala; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Depression; Dose-Response Relationship, Drug; Exploratory Behavior; Hemoglobins; Immunoassay; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Subcutaneous; Ligands; Male; Mice; Microdialysis; Oxytocin; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Receptors, Oxytocin; Time Factors; Up-Regulation | 2010 |